Covid symptoms have largely stayed the same over the last few years: cough, congestion, fever, a sore throat, nausea, ...

A detailed examination of how patients respond to the drug at various times and doses provides greater context to a recent ...

Shares of the battered biotech Vir Biotechnology were up more than 70% on Wednesday, as the company reported its first ...

InflaRx N.V. IFRX shares gained 7.7% on Wednesday following the European Commission's (EC) approval of marketing ...

Patients with multiple myeloma (MM) can experience diminished immune responses during prolonged treatment; however, mRNA ...

“We are about five years into the pandemic, and yet there are not yet any federally-approved treatments for long Covid,” ...

A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 in 2021 are less effective in patients with autoimmune diseases.

Further, the company estimates that every clinical variant reported in the CDC COVID Tracker since the Omicron BA.1 lineage has been susceptible to pemivibart, even if untested, due to the ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

The first severe human case of bird flu was recently reported in the U.S. Here are some ways the U.S. may be repeating the ...

New findings from the NIH RECOVER Initiative suggest that SARS-CoV-2 infection may be associated with an increased risk of ME ...